SUNPHARMA · Healthcare
Not filed yet. The deadline is 30 May 2025.
| Q2 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|
| Revenue | ₹4,548 cr | ₹5,741 cr | ₹6,142 cr |
| YoY | — | — | +35% |
| EBITDA margin | 26.0% | 34.2% | 27.9% |
| Other income, % of PBT | 11% | 9% | 7% |
| Exceptional items | — | −₹31.5 cr | — |
| Tax rate | 16% | 25% | 28% |
| Net profit | ₹564 cr | ₹1,115 cr | ₹871 cr |
| YoY | — | — | +54% |
| Core profit YoY | — | — | +87% |
| EPS | ₹2.40 | ₹4.60 | ₹3.60 |
| Flags | · | · | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.